The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer

被引:16
|
作者
Al-Sahaf, Sarmad [1 ]
Hunter, Keith D. [1 ]
Bolt, Robert [1 ]
Ottewell, Penelope D. [2 ]
Murdoch, Craig [1 ]
机构
[1] Univ Sheffield, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England
[2] Univ Sheffield, Med Sch, Dept Oncol & Metab, Beech Hill Rd, Sheffield, S Yorkshire, England
基金
英国医学研究理事会;
关键词
head and neck cancer; human papillomavirus; fibroblast; tumour microenvironment; cytokine; leukocyte; SQUAMOUS-CELL CARCINOMA; ORAL-CAVITY; HEAD; SURVIVAL; LYMPHOCYTES; MECHANISMS; EXPRESSION; RECEPTORS; PROGNOSIS; MONOCYTES;
D O I
10.1002/ijc.31852
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) is now recognised as a major aetiological agent in the pathogenesis of oropharyngeal carcinoma (OPC). HPV-positive tumours are associated with better outcomes compared to HPV-negative tumours, possibly due to differences in their aetiology and/or the tumour microenvironment. Increased numbers of tumour-associated leukocytes have been observed in many cancers including OPC, with variable influence on prognosis depending on the leukocyte subpopulation investigated. Whether HPV status influences leukocyte recruitment to OPC remains unknown. This in-vitro study examined differences in the chemoattractant capacity of HPV-positive and HPV-negative OPC cell lines. Gene and protein expression analysis demonstrated that whilst both monocultures of HPV-positive and HPV-negative cell lines, along with normal tonsillar fibroblasts (NTF), expressed low chemokine levels, NTF cultured with conditioned medium from HPV-negative OPC cells expressed significantly higher levels of all chemokines tested compared to NTF incubated with the medium from HPV-positive OPC cell lines. HPV-negative OPC lines expressed IL-1 beta mRNA whereas HPV-positive cells did not, and NTF constitutively expressed IL-1R1. Pre-treatment with the IL-R antagonist, anakinra or siRNA to IL-1R1 significantly reduced chemokine secretion from NTF stimulated with conditioned medium from HPV-negative tumour cells or recombinant IL-1 beta (p < 0.05). These data suggest that secretion of chemokines is driven by the interaction between HPV-negative OPC cells and stromal fibroblasts through an IL-1/IL-1R-mediated mechanism that is less prominent within the HPV-positive tumour microenvironment. These observations may explain differences in leukocyte sub-populations recruited to HPV-positive versus negative OPC and indicate that HPV status is a key determinant in controlling the inflammatory tumour microenvironment.
引用
收藏
页码:334 / 344
页数:11
相关论文
共 5 条
  • [1] Cancer cell-derived IL-1α induces IL-8 release in endothelial cells
    Jung-Hyo Rhim
    Sin-Ae Kim
    Ji-Eun Lee
    Dong-Jo Kim
    Hong Keun Chung
    Kum-Joo Shin
    Junho Chung
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 45 - 50
  • [2] Cancer cell-derived IL-1α induces IL-8 release in endothelial cells
    Rhim, Jung-Hyo
    Kim, Sin-Ae
    Lee, Ji-Eun
    Kim, Dong-Jo
    Chung, Hong Keun
    Shin, Kum-Joo
    Chung, Junho
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (01) : 45 - 50
  • [3] Increased Abundance of Tumour-Associated Neutrophils in HPV-Negative Compared to HPV-Positive Oropharyngeal Squamous Cell Carcinoma Is Mediated by IL-1R Signalling
    Al-Sahaf, Sarmad
    Hendawi, Naeima B.
    Ollington, Bethany
    Bolt, Robert
    Ottewell, Penelope D.
    Hunter, Keith D.
    Murdoch, Craig
    FRONTIERS IN ORAL HEALTH, 2021, 2
  • [4] Human Lung Cancer-Derived Immunosuppressive Plasmacytoid Dendritic Cells Release IL-1α in an AIM2 Inflammasome-Dependent Manner
    Sorrentino, Rosalinda
    Terlizzi, Michela
    Di Crescenzo, Vincenzo G.
    Popolo, Ada
    Pecoraro, Michela
    Perillo, Giuseppe
    Galderisi, Antonio
    Pinto, Aldo
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (11): : 3115 - 3124
  • [5] A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
    Elssner, A
    Duncan, M
    Gavrilin, M
    Wewers, MD
    JOURNAL OF IMMUNOLOGY, 2004, 172 (08): : 4987 - 4994